NPA Estonian Centre for Standardisation and Accreditation confirms that Asper Biogene LLC conforms to the requirements of EVS-EN ISO 15189:2022 as medical laboratory in the field of genetics. Accreditation scope was expanded by 3 tests:
- Repeat expansions in the DMPK gene associated with the myotonic dystrophy, type 1 (DM1)
- Repeat expansions in the CNPB gene associated with the myotonic dystrophy, type 2 (DM2)
- Sequencing of the ORF15 region of the RPGR gene associated with the X- linked Retinitis Pigmentosa.